Cross-margining at CME slowed by practical challenges

Hurdles

Nearly five months on from the start of mandatory clearing in the US, only a handful of clients at two dealers – Barclays and Citi – have been able to take advantage of cross-product margining between listed and over-the-counter derivatives at CME Group, the first venue to offer the service.

The operational challenges faced by dealers and clients – which include finding the optimal offsets and rearranging clients' portfolios to allow them to take advantage – mean take-up has been slower than

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: